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INTRODUCTION   
              
The understanding of etiopathogenesis of peptic ulcer, expressed as 
gastritis, gastric ulcer, duodenitis, duodenal ulcer has been revolutionised during 
last decade with the discovery in 1983, of a new pathogen categorized as 
Helicobacter Pylori by Warren and Marshall. 67.68 Several reports have 
subsequently supported the association of H.pylori as a major etiological factor in 
the development of peptic ulcer disease 50, 78 and recent reports also suggest its 
association with gastric carcinoma and lymphoma.82,88  Bacterium has been 
classified as class I definite gastric carcinogen to human  77,83,97  
 
A prospective study of adult presenting with upper abdominal pain,20 
dyspepsia, vomiting, haematemesis is undertaken to evaluate the relationship of 
this symptomcomplex to inflammatory gastroduodenal lesions with special 
reference to H.pylori infection. The clinical endoscopic findings, rapid urease test 
and histopathological evaluation of gastric antral specimen with special stains 16 to 
demonstrate the organism are presented and analysed.   
 
Regarding the histopathology, previous studies on the pathologic changes 
of gastric mucosa, colonized by H.pylori have markedly focused on inflammatory 
reaction.  
 
In addition to more common inflammatory cell infiltration it is only 
recently the histopathologic effect of H.pylori on gastric epithelium at light 
microscopic level has been stressed and this has been studied systematically,  
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describing striking changes in surface epthelium and attributing them as specific 
for H.pylori colonization and correlating them with type of cytotoxin 30,17,18 
,production and risk of peptic ulcer.50,53 H.pylori infection can be diagnosed by 
invasive 12,14,66 (requiring endoscopy) and non invasive technique. 22,29,64 
 
In this study the various methods of identification of H.pylori and 
histopathological features associated H.pylori in gastric mucosa in patients, 
presenting with dyspepsia are discussed and described in detail paying particular 
attention to histopathological effects of H.pylori on epithelial cells and   evaluate 
the gastric mucosa as per updated Sydney system.23,24,70,88 
 
In addition, the recent literature regarding epidemiology, clinical features, 
pathogenesis of infection is also reviewed.   
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AIM OF STUDY 
 
¾ The Aim and objective of this study find out the association of H.pylori 
with gastric lesions in endoscopic biopsy specimen in semi-urban regions.  
¾ To study the specificity and sensitivity of Rapid Urease test. 
¾ To evaluate the usefulness of Giemsa stain in addition to histopathological 
examination for identification of H.pylori. 
¾ To evaluate the gastric mucosa as per the modified Sydney system. 
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REVIEW OF LITERATURE 
Embryology: 
 The epithelial lining of the various parts of gastrointestinal tract is that of 
endodermal origin. 
Stomach:  
 The stomach is first seen as a fusiform dilatation of the foregut just distal 
to the oesophagus.  Its distal border is attached to the posterior abdominal wall by 
a fold of peritoneum called the dorsal mesogastrium.  Its ventral border is attached 
to the septum transversum by another fold of peritoneum called the ventral 
mesogastrium. 
 The stomach undergoes differential growth resulting in a considerable 
change in the shape and orientation.  The original ventral border comes to face 
upward and to the right and becomes the lesser curvature.  The dorsal border now 
points downwards and to the left and becomes greater curvature.  The original left 
surface becomes its anterior surface and the original right surface becomes the 
posterior surface. 
Anatomy of stomach: 
 The stomach extends from just left of the midline where it is joined to the 
oesophagus, to just right of the midline where it is connected to the duodenum.  It 
resembles a large gland. 
 The concavity of the right, the inner curve is called the lesser curvature, 
and the convexity of the left, outer curve is the greater curvature. An angle along 
the lesser curve, the incisura angularis, marks the approximate point at which the 
stomach narrow prior to its junction with the duodenum. The most distal and 
narrow portion of the stomach is termed the pylorus. 
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 In the empty state, the stomach is contracted and its mucosa and 
submucosa are thrown up into distinct folds called rugae. When distended with 
food, the rugae are “ironed out” and flat.  It secretes a complex of digestive 
enzymes, acid and mucus. 
The stomach is divided into 5 anatomical regions (Fig.1) 
1. Cardia – Narrow conical portion of the stomach immediately distal 
to the gastroesophageal junction. 
2. Fundus – Domeshaped portion of the proximal stomach that 
extends superolateral to the gastroesophageal junction. 
3. Body or Corpus – Comprises the remainder of the stomach 
proximal to the incisura angularis. 
4. Antrum – The stomach distal to the incisura angularis. 
5. Pylorus – The most distal and narrow portion of the stomach. 
HISTOLOGY OF STOMACH 
 The gastric wall consists of mucosa, submucosa, muscularis propria and 
serosa. 
Mucosa 
 It has two compartments; the superficial foveolar compartment and the 
deep glandular compartment. 
Foveolar compartment 
 It consists of surface epithelial cells lining the entire mucosal surface as 
well as gastric pits. 
 It is relatively uniform throughout the stomach. The surface epithelium 
shows a regular picket – fence arrangement, with a plentiful diffuse secretion of 
mucus.  All foveolar cells secrete mucus, in contrast to the scattered goblet cells, 
between absorptive cells, lining the intestine.  The cells are tall, with regular basal 
 6
nuclei.  The epithelial surface appears flat on light microscopy.  This epithelium 
lines the gastric pits (foveolae). 
 In the body of the stomach, the pits are short tubules, with long, closely 
packed glands opening into them. Figno7. When seen in three dimensions, the pits 
in the antrum have a partial cerebriform structure of complex folds. The mucus 
secreting glands branch from the base of these pits. The superficial parts of the 
gland form narrow straight tubules, the gland neck, lined by epithelium similar to 
the outer surface but with smaller cells. 
 A primary function of the foveolar cells is the secretion of mucus.  A 
dense layer of mucus globules fills the superficial one third to two thirds of the 
cells.  Normal foveolar mucus consists mainly of neutral glycoprotein, which is 
strongly “Periodic Acid Schiff (PAS)” positive and stain weakly with Alcian blue, 
whereas intestinal  mucins stain strongly with Alcian blue. 
 A combination of Alcian blue and PAS [ABpH2.5PAS] shows these 
differences practically and well appreciated.  Foveolar mucus stains as a rich 
magenta red, in contrast the intestinal mucus stains a variety of purple and indigo 
blue colors as a result of the presence of acid glycoproteins. 
 One notable exception is the secretion of Brunner’s glands in the 
duodenum, which stains a brighter red than the gastric foveolar mucus.  Brunner’s 
glands, however, are deep to the muscularis mucosae and are irregular and 
glandular outline, in contrast to foveolae. 
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Glandular Compartment 
 It exhibits major difference in thickness and in glandular composition in 
different regions of stomach.  It consists of gastric glands, which vary between 
anatomic regions. 
1. Cardiac glands contain mucus secreting cells only. 
2. Oxyntic glands (also called gastric / fundic glands) found in the fundus and 
body and contain parietal cells, chief cells and scattered endocrine cells. 
3. Antral or pyloric glands contain mucin secreting cells and endocrine cells. 
      The normal gastric mucosa shows another unusual feature.  It is the 
only part of the gastrointestinal tract with almost no lymphoid tissue. 
 
HELICOBACTER PYLORI 
 Before the first isolation and documentation of Helicobacter pylori from 
the human stomach in 1982, it was assumed that the human stomach was a sterile 
environment because of the high levels of acid, which would exclude it as an 
ecologic niche for any organism. 
 H.pylori was introduced into the scientific community in 1982 by 
Marshall67,68 and Warren who described a campylobacter-like bacterium that was 
seen in large numbers in the gastric mucus of patients with chronic gastritis and 
duodenal ulcers. 
Historical Perspective: 
 German scientists found spiral-shaped bacteria in the lining of the human 
stomach in 1875, but they were unable to culture it and the results were eventually 
forgotten.40 
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 Professor Walery Jaworski41 of the Jagiellonian University in Krakow 
investigated sediments of gastric washings obtained from humans in 1899. Among 
some rod-like bacteria, he also found bacteria with a characteristic spiral shape, 
which he called Vibrio Rugula.  He was the first to suggest a possible role of this 
organism in the pathogenesis of gastric diseases.  This work was included in the 
Handbook of Gastric Diseases, but it had little impact as it was written in Polish. 
 Several small studies conducted in the early 1900s demonstrated the 
presence of curved rods in the stomach of many patients with peptic ulcer and 
stomach cancer.92 
 The interest waned when an American study published in 1954 failed to 
observe the bacteria in 1180 stomach biopsies. 
 However the role of bacteria in stomach diseases was rekindled in the 
1970s with the visualization of bacteria in the stomach of gastric ulcer patients. 
 The bacterium had also been observed in 1979 by Australian pathologist 
Robin Warren, 94 who did further research on it with Australian physician Barry 
Marshall beginning in 1981.  After numerous unsuccessful attempts at culturing 
the bacteria from the stomach, they finally succeeded in visualizing colonies in 
1982 when they unintentionally left their Petri dishes incubating for 5 days over 
the Easter weekend. 
 In their original paper, Warren and Marshall contended that most stomach 
ulcers and gastritis were caused by infection by this bacterium and not by stress or 
spicy food as had been assumed before.13 
 Although there was some skepticism initially, within several years, 
numerous research groups verified the association of H.pylori with gastritis. 
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 To demonstrate the role of H.pylori with gastritis, Marshall drank a beaker 
of H.pylori.  He became ill several days later with nausea and vomiting.  An 
endoscopy performed ten days after inoculation revealed signs of gastritis and the 
presence of H.pylori. These results suggested that H.pylori was the causative 
agent of gastritis. 
 Marshall and Warren also showed that antibiotics were effective in the 
treatment of many cases of gastritis. 
 In 1987 the Sydney gastroenterologist Thomas Borody24, 85,86 invented the 
first triple therapy for the treatment of duodenal ulcers. 
 In 1994, the National Institute of Health (USA) published an opinion 
stating that most recurrent duodenal and gastric ulcers were caused by H.pylori 
and recommended antibiotics in the treatment regimen. Warren and Marshall were 
awarded the Nobel Prize in Medicine in 2005 for their wonderful work on 
H.pylori.94 
 
EPIDEMIOLOGY 
 At least half the world’s population is infected by H.pylori making it the 
most widespread infection in the world.13,48  Actual infection rates vary from 
nation to nation.  The Third World has much higher infection rates than the West 
(Western Europe, North America, Australia), where the rates are estimated to be 
around 25%. 
 Infections are usually acquired in early childhood in all countries. 
However, the infection rate of children in developing nations is higher than in 
industrialized nations, probably due to poor sanitary conditions. 
 In developed nations it is currently uncommon to find infected children.  
The percentage of infected people increases with age, 50% infected are over the 
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age of 60 compared with 10% between 18 and 30 years of age. The higher 
prevalence among the elderly reflects the fact that they were infected from 
childhood.7 
 Prevalence appears to be higher in African – American and Hispanic 
population, although this is likely related to socioeconomic rather than racial 
factors.13,49,94 The lower rate of infection in the West is largely attributed to higher 
hygiene standards and widespread use of antibiotics.  Despite high rates of 
infection in certain areas of the world, the overall frequency of H.pylori infection  
is declining.  However, antibiotic resistance is appearing in H.pylori and many 
metronidazole and clarithromycin resistant strains are seen in most parts of the 
world. 
 H.pylori is contagious, although the exact route of transmission is not 
known.  Person-to-person transmission by either the oral-oral or fecal-oral route is 
most likely.13,55 Consistent with these transmission routes, the bacteria have been 
isolated from feces, saliva and dental plaque of some infected people.49 
 Transmission occurs mainly within families in developed nations yet can 
also be acquired from the community in developing countrie H.pylori may also be 
transmitted orally by means of fecal matter through the ingestion of waste tainted 
water.  Hence a hygienic environment could help to decrease the risk of H.pylori 
infection.13 
 
MORPHOLOGY 
 H.pylori is a spiral to curved, rod shaped, gram negative microaerophilic 
bacterium about 3 microns long with a diameter of about 0.5 micron.  It has 4 to 7 
polar sheathed flagella, which enable the bacterium to move freely in viscous 
environments such as gastric mucus.94 
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 This bacterium is the human-adapted helicobacter primarily found in the 
gastric mucosa and areas of gastric metaplasia in the duodenum and occasionally 
in Meckel’s diverticulum and rectum. 
 
BIOCHEMICAL CHARACTERISTICS 
 H.pylori is urease, catalase and oxidase positive.  The urease activity is 
striking and the amounts produced have allowed accurate diagnosis in patients by 
direct detection of the enzyme in gastric biopsy specimens and by breath tests 
using carbon isotopes labeled with urea. 
 Many roles have been proposed for urease enzyme.  It is known to be 
important for colonization and survival of the bacterium in the gastric 
environment.85,90 
 The hydrolysis of urea to ammonia by urease could have a buffering 
effect, protecting the bacterium from acidity. 
 In-vitro studies have shown that helicobacter pylori cannot survive in 
acidic condition without the presence of urea, and urea inhibits its growth in 
alkaline conditions.94,48,82 Urease also has been proposed as an important virulence 
factor. 
 
GENETICS 
 In 1997, the complete genomic sequence of H.pylori strain 26695 was 
published.61,68 This bacterium has a single circular chromosome of 1,667,867 base 
pairs and 1590 predicated coding sequence of which 1091 matched database 
sequence of genes are known from other organisms. 
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PATHOPHYSIOLOGY 
 To colonize the stomach H.pylori must survive in the acidic pH of the 
lumen and burrow into the mucus to reach its niche, close to the stomach’s 
epithelial cell layer. The bacterium has flagella and moves through the stomach 
lumen and drills into the mucoid lining of the stomach.55 
 Many bacteria can be found deep in the mucus, which are continuously 
secreted by mucous cells and removed on the luminal side.  To avoid being 
carried into the lumen, H.pylori senses the pH gradient within the mucus layer by 
chemotaxis and swims away from the acidic contents of the lumen towards the 
more neutral pH environment of the epithelial cell surface.28,57 
 H.pylori is also found on the inner surface of the stomach epithelial cells 
and occasionally inside epithelial cells,91 It produces adhesions which bind to 
membrane-associated lipids and carbohydrates and help it adhere to epithelial 
cells.  Adhesin BabA binds to the Lewis b antigen displayed on the surface of 
stomach epithelial cells.82 
 H.pylori produces large amounts of the enzyme urease, molecules of 
which are localized inside and outside of the bacterium.  Urease breaks down urea 
(which is normally secreted into the stomach) to carbon dioxide and ammonia 
(which neutralizes gastric acid).  The survival of H.pylori in the acidic stomach is 
dependent on urease, and it would eventually die without the enzyme. The 
ammonia that is produced and other products of H.pylori such as protease, 
vacuolating cytotoxin A(VacA), and certain phospholipases are toxic to the 
epithelial cells.42,30,17 
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 Colonization of the stomach by H.pylori results in chronic gastritis.  The 
severity of the inflammation is likely to underlie H.pylori related diseases.88,90 
Duodenal and stomach ulcers result when the consequences of inflammation allow 
the acid and pepsin in the stomach lumen to overwhelm the mechanisms that 
protect the stomach and duodenal mucosa from these caustic substances. 
 The type of ulcer that develops depends on the location of chronic 
gastritis, which occurs at the site of H.pylori colonization. The acidity within the 
stomach lumen affects the colonization pattern of H.pylori and therefore 
ultimately determines whether a duodenal or gastric ulcer will form. 
 In people producing large amounts of acid, H.pylori colonizes the antrum 
of the stomach to avoid the acid – secreting parietal cells located in the corpus 
(main body) of the stomach. The inflammatory response to the bacteria induces G 
(gastrin – producing) cells in the antrum to secrete the hormone gastrin, which 
travels through the bloodstream to the corpus. Gastrin stimulates the parietal cells 
in the corpus to secrete even more acid into the stomach lumen.  Chronically 
increased gastrin level eventually cause the increase in the number of parietal 
cells, further increasing the amount of acid secreted. The increased acid load 
damages the duodenum and ulceration may eventually result. 
 In contrast, gastric ulcers are often associated with normal or reduced 
gastric acid production, suggesting that the mechanisms that protect the gastric 
mucosa are defective. In these patients H.pylori can also colonize the corpus of 
the stomach, where the acid-secreting parietal cells are located.  However, chronic 
inflammation induced by the bacteria causes further reduction of acid production 
and eventually, atrophy of the stomach lining, which may lead to gastric ulcer and 
increases the risk for stomach cancer.55,70 
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 About 50-70% of H.pylori strains in Western countries carry the Cag 
Pathogenicity Island (Cag PAI).18,53 Western patients infected with strains 
carrying the Cag (cytotoxin – associated antigen) PAI have a stronger 
inflammatory response in the stomach and are at a greater risk of developing 
peptic ulcers or stomach cancer than those infected with strains lacking the island. 
Following attachment of H.pylori to stomach epithelial cells, the type IV secretion 
system expressed by the Cag PAI “injects” the inflammatory inducing agent 
peptidoglycan from their own cell wall into the epithelial cells.  The injected 
peptidoglycan is recognized by the cytoplasmic immune sensor Nodl, which then 
stimulates expression of cytokines that promote inflammation. 
 The type IV secretion apparatus also injects the Cag PAI-encoded protein 
CagA into the stomach’s epithelial cells, where it disrupts the cytoskeleton, 
adherence to adjacent cells, intracellular signalling, and other cellular activities. 
Once inside the cell the CagA protein is phosphorylated on tyrosine residues by a 
host cell membrane – associated tyrosine kinase. 
 Pathogenic strains of H.pylori have been shown to activate the epidermal 
growth factor receptor (EGFR), a membrane protein with a tyrosine kinase 
domain.  Activation of the EGFR by H.pylori is associated with altered signal 
transduction and gene expression in host epithelial cells that may contribute to 
pathogenesis.  It has also been suggested that a terminal region of the CagA 
protein (amino acids 873-1002) can regulate host cell gene transcription 
independent of protein tyrosine phosphorylation. 
 Two related mechanisms by which H.pylori could promote cancer are 
under investigation.  One mechanism involves the enhanced production of free 
radicals near H.pylori and an increased rate of host cell mutation.  The other 
proposed mechanism has been called a “perigenetic pathway” and involves 
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enhancement of the transformed host cell phenotype by means of alterations in 
cell proteins such as adhesion proteins. It has been proposed that H.pylori induces 
inflammation and locally high level of TNF- α and IL-6 (interleukin-6). 
According to the proposed perigenetic mechanism, inflammation-associated 
signaling molecules such as TNF- α  can alter astric epithelial cell adhesion and 
lead to the dispersion and migration of mutated epithelial cells without the need 
for additional mutations in tumor suppressor genes such as genes that code for cell 
adhesion proteins. 
 H.pylori colonizes the stomach and induces chronic gastritis. The 
bacterium persists in the stomach for decades in most people. Most individuals 
infected by H.pylori will never experience clinical symptoms despite having 
chronic gastritis.  Approximately 10-20% of those colonized by H.pylori will 
ultimately develop gastric and duodenal ulcers. H.pylori infection is also 
associated with a 1-2% lifetime risk of stomach cancer and a less than 1% risk of 
gastric MALT lymphoma. 
 It is widely believed that in the absence of treatment, H.pylori infection-
once established in its gastric niche-persists for life. In the elderly, however, it is 
likely that infection can disappear as the stomach’s mucosa becomes increasingly 
atrophic and inhospitable to colonization.  The proportion of acute infections that 
persist is not known, but several studies that followed the natural history in 
populations have reported apparent spontaneous elimination. 
 While H.pylori has been disappearing from the stomach of humans, the 
incidence of the related disorders acid reflux disease, Barrett’s esophagus, and 
esophageal cancer have been rising dramatically. 
 In 1996, Martin J. Blaser advanced the hypothesis that H.pylori has a 
beneficial effect, by regulating the acidity of the stomach contents, it lowers the 
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impact of regurgitation of gastric acid into the esophagus. The hypothesis is not 
universally accepted as several randomized controlled trials failed to demonstrate 
worsening of acid reflux disease symptoms following eradication of H.pylori. 
 Nevertheless, Blaser has refined his view to assert that H.pylori is a 
member of the normal flora of the stomach. He postulates that the changes in 
gastric physiology caused by the loss of H.pylori account for the recent increase in 
incidence of several diseases, including Type-2 diabetes, obesity and asthma His 
group has recently shown that H.pylori colonization is associated with a lower 
incidence of childhood asthma. 
 
CLINICAL OUTCOMES ASSOCIATED WITH H.PYLORI 
Peptic ulcer(Fig. 3,4) 
 H.pylori associate strongly with duodenal ulcers, than with gastric ulcers. 
Gastric metaplasia of the duodenal mucosa is common in places near the duodenal 
ulcers. 
Carcinoma 
 There is a growing body of evidence that H.pylori is a precursor of 
carcinoma of the body and antrum of the stomach. H.pylori infection causes 
chronic gastritis and it leads to development and progression of atrophic gastritis 
and intestinal metaplasia, which are considered precursor lesions of gastric cancer.  
Some strains of H.pylori may be more carcinogenic than others, especially CagA-
positive bacteria. 
 
MALT Lymphoma 
 Primary Non-Hodgkin Lymphoma (M+NHL) of the stomach is a relatively 
rare malignant disorder, accounting for about 5% of gastric tumors.  The cause of 
 17
primary gastric NHL had been unknown because by definition NHLs are 
malignant clonal diseases of the lymphatic tissue, and the stomach is a site that is 
normally considered to be devoid of organized lymphoid tissue.82,88,90 
 The association between Mucosa associated lymphoid tissue (MALT) 
lymphoma and H.pylori was postulated for the first time in 1998 with the 
recognition that the cause of acquired gastric MALT is chronic infection with 
H.pylori. Wother-spoon et al were the first to investigate the presence of H.pylori 
in larger numbers of gastric lymphomas of the MALT type (MALToma). H.pylori 
was detected in 92% of cases. 
 They suggested that H.pylori (and Helicobacter heilmannii) might trigger 
the acquisition of MALT in the gastric mucosa, and this lymphoid tissue is 
thought to harbor the precursor cells for MALT NHL. These precursor cells 
changes gradually into malignant lymphoma cells with autonomous and 
uncontrolled growth by accumulation of genetic alteration, mutations, deletions 
and amplifications (i.e., trisomy 3 and 7) 
 
GASTRIC PATHOLOGY ASSOCIATED WITH H.pylori 
 The active changes defined by Whitehead et al  are linked closely with 
H.pylori infection in humans.  These changes, together with non-specific chronic 
gastritis, usually accompany helicobacter infection.   
Three features make the diagnosis: 
1. The presence of uniform small curved bacilli, closely adherent to the 
surface of the epithelium 
2. A typical infiltration of the epithelium by polymorphonuclear neutrophil. 
3. The typical epithelial distortion, which is specific but often absent. 
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Identification and distribution of organism 
 The bacteria play an important part in the histopathology of H.pylori 
gastritis.  Small numbers of H.pylori may still be difficult to find.  A search with 
the oil immersion lens usually reveals any organisms.  Single Helicobacter-like 
organisms can be recognized.  [Small, pale, curved, well formed bacilli]. 
Immunoperoxidase antibodies are also available.  Polymerase chain reaction 
provides a sensitive and specific method of identification. 
 H.pylori show marked variation in number and distribution.  They 
proliferate mostly on the superficial foveolar epithelium.  Fewer bacilli grow in 
the gastric mucosal pits. 
 Occasional Helicobacter organism grows in the inflamed gland necks but 
almost never in the glands.  They tend to adhere closely to the surface of the 
epithelial cells, particularly in the antrum, often palisading.  Unattached bacilli are 
commonly seen deep in the mucus. 
 The H.pylori is of unusual length in occasional biopsy specimens.  They 
may be less than half or almost double the usual length.  In most well-fixed 
specimens, they are small, pale, curved bacilli and remarkably constant in 
appearance. Single bacillus is easy to identify with oil immersion microscopy. 
 H.heilmannii is larger and more tightly coiled.  They tend to infiltrate into 
the glands, often in the fundus, and produce remarkably little reaction.  In contrast 
to H.heilmannii, H.pylori is rare in the actual corpus mucosa gastric glands (as 
distinct from the necks of the glands). 
 Foreign bacteria are common on gastric biopsy specimens. They show 
variation in size than H.pylori, which are larger with darker staining than others. 
They are usually seen above the mucus secretion but not on the epithelial cell 
surface. 
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 H.pylori grows well on intact antral mucosa and also in the fundus, usually 
in smaller numbers than in the antrum. When the fundal mucosa is intact, the 
Helicobacter organisms seen less firmly attached to the epithelial surface. They 
often float deep in the mucus layer. 
 H.pylori grows only on gastric-type epithelium, and a dense proliferation 
of the bacteria stops within one cell of a focus of mature intestinal metaplasia. 
 Sometimes few bacteria grow on areas of partial or atypical metaplasia, 
with PAS-positive mucus in the epithelial cells between the goblet cells. 
 They sometimes grow on the areas of gastric metaplasia in the duodenum, 
usually patchy and fewer in number than the antrum. Infected areas often show 
active inflammation, similar to the stomach. 
 The bacteria rarely grow in the oesophagus but can do so in Barrett’s 
esophagitis with well-formed gastric metaplasia near the gastroesophageal 
junction.  
 Grading of morphological variables are carried out in an attempt to 
improve the agreement among different observers. In the updated Sydney system 
a visual analogue scale was provided to assist in grading as mild, moderate, 
marked and a set of guidelines for its application have been designed.  
 
Graded Variables: 
1. H.pylori density: 
 H.pylori is small, curved, slightly basophilic bacillus that is most easily 
seen in the mucus layer overlying the gastric surface epithelium, with gastric pits, 
rarely intra cellularly. In a given biopsy the organism may be dense in one area of 
section and absent or sparse in another.   
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 Evaluation of H.pylori density is performed as mild, moderate or marked 
in the areas where it normally resides. Using the visual analogue scale provides 
avoiding the inclusion of entire length of specimen by upgraded Sydney 
systems.24 70,82,88, 
Polymorphonuclear Neutrophil infiltration: 
 Activity implies the presence of Neutrophil polymorphs in a background 
of chronic inflammation 49,90,  Neutrophil activity is almost universal phenomenon 
in H.pylori gastritis.72 Neutrophils may be seen in lamina propria within 
epithelium, (particularly in the region of glandular neck) and within foveolar 
lumen, where they form pit abscess. Neutrophils are very sensitive indicator. The 
features described by Whitehead at a as active gastritis almost always are 
associated with H.pylori infection. 
 H.pylori and epithelial Neutrophil show an almost absolute correlation.  
The Neutrophils infiltrate with a typical pattern, not seen otherwise.  They usually 
infiltrate the epithelium of the necks of the glands, adjacent to the base of gastric 
mucosal pits.  As a rule, this infiltration is most obvious in the gastric antrum.  
The typical infiltration is focal. 
 Superficial epithelial neutrophil, without involvement of the gland necks 
are less specific for H.pylori infection.  The severity of the changes is of less 
diagnostic importance.  These changes are related to the presence but not the 
number of H.pylori. 
 Neutrophil infiltrating the stroma (the mucosal lamina propria) are not 
clearly related to H.pylori infection.  Neutrophil infiltrate into the lumen of some 
gland necks and may fill the overlying pits.  It results in micro abscesses, 
resembling the crypt abscesses of Ulcerative colitis or Crohn’s disease. 
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Chronic inflammation – The normal gastric mucosa contains only individual 
scattered chronic inflammatory cells in laminar propria. They are indicators of 
chronic gastritis. The cellular infiltrate contains effectors of immune response 
including CD4 , CD8, T-Lymphocytes, B-lymphocytes, plasma cells, monocytes, 
mast cells, eosinophils.   
Normal number of gastric mucosal mononuclear cells in laminar propria is 
viewed as maximum 2-5 lymphocytes, plasma cells, macrophages/ HPF. 91 
>5 lymphocytes per 100 epithelial cells indicate inflammation. Chronic 
inflammatory cells have been shown to disappear after eradication of H.pylori.   
Atrophy: 
Intestinal Metaplasia  
Specific epithelial changes 
 Normally epithelial cells look rigid, with a picket-fence arrangement, a flat 
surface, regular small round basal nuclei, and plentiful superficial mucus 
secretion.  The main specific change in the foveolar epithelium is a 
disorganization of the structure of the epithelial cells.  This may be mild, 
moderate, or severe and diffuse, patchy, or focal.90 
 The mildest recognizable specific change consists of a definite cobblestone 
irregularity of the epithelial surface.  The surface is no longer flat; the cells bulge 
out72. 
 When the change are severe, the epithelial cells show ameboid features.  
The cells lose their picket – fence arrangement and the basal nuclear polarization. 
The epithelium often appears thickened, with irregular nuclei scattered 
throughout. 
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Microcrypts 
 Microcrypts, small spaces or virtual spaces within the foveolar epithelium, 
are often seen with H.pylori.  Adjacent epithelial cells form microcrypts by 
turning in on each other, producing an apparent intraepithelial mucus-secreting 
gland. Microcrypts are not specific for Helicobacter, but only infected mucosa 
shows them easily. Small groups of the bacteria often fill the microcrypts. One of 
the last places where the bacteria collect is in the microcrypts. 
Mucous secretion 
 Factors that alter cell function tend to reduce secretion.  Such factors 
include epithelial proliferation, inflammatory damage, atrophy and cellular atropia 
or dysplasia.  Reduced mucus secretion by the foveolar cells is observed with 
H.pylori infection.  The gastritis, rather than the Helicobacter may cause this 
change.  They reduced mucous secretion which could be a combination of direct 
bacterial effect and the associated inflammatory damage.72 
 Reduced mucus secretion with a diffuse cobblestone change gives an 
appearance resembling a string of beads [PAS stain].  These changes are well seen 
in the antrum. 
 Atrophy of gastric mucosa is defined as loss of glandular tissue. Loss of 
glands may follow erosion or ulceration of mucosa with destruction of glandular 
layer result from prolonged inflammatory process where individual cells undergo 
destruction of piecemeal fashion.70 Helicobacter infiltration and the changes of 
active gastritis are most obvious in the gastric antrum.  The appearance of atrophy 
in the antrum is deceptive, however. Atrophy is easier to recognize in the corpus, 
where it is mild, focal or absent. 
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 The glands become separated, with increasing loss of chief and parietal 
cells.  The inflammatory infiltration is mild and superficial.  The most severe 
cases show widespread intestinal metaplasia.  In such areas, Helicobacter is sparse 
or absent, and the stromal inflammation decreases. 
 Intestinal Metaplasia is a complex process in which superficial and gastric 
pit lining epithelial changes, both morphologically and histochemically. 
Metaplastic epithelium can be identified as resemblance of lining epithelial cells 
of small intestine [intestinal metaplasia].  The basic histologic structure of the 
gastric mucosa remains intact.  Metaplastic changes are mainly seen in the 
superficial part of the epithelium.  When metaplasia extends into the glands, they 
usually show marked distortion and atrophy, but they do not resemble intestinal 
crypts, which are much shorter and more regular. 
 The metaplastic epithelium can show a wide range of appearances.  In type 
I intestinal metaplasia,72,82 the metaplastic epithelium resemble mature small 
intestinal epithelium.  In type II metaplasia, the epithelium frequently undergoes a 
partial, incomplete, or atypical metaplastic change.  This metaplasia may consist 
of scattered goblet cells in regular epithelium showing a variable amount of 
gastric mucus secretion.  In type III metaplasia, foveolar-like cells are large with 
nuclear irregularity, poor mucus secretion and poorly formed goblet cells. 
 There is marked difference between the superficial epithelium of the 
stomach and the intestine. Gastric foveolar epithelium secretes neutral 
glycoproteins diffusely from all cells.  The intestine secretes acidic mucins from 
scattered goblet cells, separated by nonsecretory cells.  A standard H&E  stain 
shows the goblet cells and microvilli, but small foci of metaplasia are easy to 
miss.  Specific stains for mucus give a much more sensitive and definite result.  
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Alcian-PAS provides and excellent method of finding metaplasia quickly and 
easily in the stomach or duodenum. 
 The relationship between Helicobacter and metaplasia is complex.  
H.pylori do not grow on intestinal epithelium, including intestinal metapasia.  
Because of this fact, larger areas of mature intestinal metaplasia in the stomach 
show reduced inflammation, with regular epithelium and no active changes.  
Other histological changes: - Non-graded variables  
Surface epithelial changes: Mucin depletion, loss of nuclear polarity, 
nuclear enlargement, irregular ragged surface epithelial pits, micro erosion, 
ulceration. The surface epithelial changes are marked in pit regions than in surface 
epithelium.  
Lymphoid Follicles: Lymphoid aggregates with active germinal centers are 
characteristics of H.pylori especially in children.  
Foveolar hyperplasia: Increased length and tortuosity of the foveolae combined 
with expansion of the proliferative compartment as an increase in nuclear size 
relative to mucin depleted cytoplasm - as a result of cytokine stimulation in 
chronic gastritis (chemical gastritis). 
Pseudo pyloric metaplasia: --When the site of gastric biopsy in uncertain glands 
can be differentiated from true antral glands in which endocrine cells associated 
with metaplastic glands do not include “G” cells. whereas, they routinely 
accompany antral glands. Furthermore, pseudopyloric glands contain both 
Pepsinogen I and II, whereas the true antral glands show only Pepsinogen II. 
Discriminating between two glands are of great value correctly localizing and 
classifying atrophic gastritis.  
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Endocrine cell hyperphasia: In auto immune gastritis, hypochlorhydria or achlor 
hydria leads to G-cell hyperplasia to which the exposed ECL cells in the oxyntic 
glands undergo hyperplasia.       
 
Stromal changes 
 H.pylori causes nonspecific inflammation of the mucosal stroma (lamina 
Propria).  This inflammation varies considerably and usually is most obvious in 
the antrum. The most striking change is an infiltration of lymphoid cells, which 
are almost absent in the normal stomach.  Often a moderate diffuse infiltration of 
lymphocytes extends through the full thickness of the mucosa to the mucosa to the 
muscularis mucosae. Other less common patterns of lymphocytic infiltration 
include fine diffuse, superficial, patchy or focal and dense diffuse.  Small follicle-
like concentration of lymphocytes are frequent fully developed lymphoid  
follicles,  with germinal centers, are uncommon. 
 Congestion and edema are common.  Patchy fibrosis accompanies more 
severe damage, often related to varying degree of glandular distortion and 
atrophy.  Other cells often present in small numbers include eosinophils and mast 
cells. 
 
Electron microscopy 
 The normal gastric epithelium consists of a sheet of well-formed 
cylindrical cells.  The superficial surface is flat, with numerous microvilli. The 
microvilli are not as numerous or well formed as those on the intestinal cells, but 
they still are plentiful and fairly regular.  Fibrils attach into the microvilli, extend 
through the cytoplasm, past the globules of mucus and the nucleus, and into the 
 26
base of the cell.  These fibrils appear to provide a skeleton that maintains the cell 
shape and internal structure, with a flat surface. 
 
 With H.pylori infection, the bacteria attach to the epithelial cells, with 
patches resembling cell junction.  They often attach to the microvilli. The 
microvilli become distorted, thickened, and reduced in number.  As the microvilli 
disappear, the fibrils also disappear.  The cells lose their skeleton and become 
somewhat ameboid.  The intercellular junctions and basal junction may weaken, 
but they remain intact and hold the cell in position.  The cell surface bulges out, 
however, giving the cobblestone appearance often seen with H.pylori infection. 
 
Changes after treatment 
 Patients with mild pathology reverted to normal within two weeks of 
treatment. The neutrophil infiltration and the active changes in the epithelium 
vanished with the bacteria.  The foveolar epithelium soon returned to normal, with 
normal mucus secretion and regular picket-fence appearance. The lymphoid 
infiltration improved slowly.  It was usually mild after twelve months and normal, 
almost absent, after seven years. 
 
DIAGNOSIS 
 H.pylori infection can be diagnosed by invasive (i.e., requiring endoscopy) 
12,14,16,85 and noninvasive techniques (i.e., techniques that do not require 
endoscopy).22,29,64  Each of the available diagnostic techniques has advantages and 
disadvantages. 
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Non-invasive techniques 
1. Serologic testing  
2. Urea breath tests 
3. Stool tests 
 
Invasive techniques 
1. Urease tests 
2. Biopsy 
3. Culture 
4. Polymerase chain reaction 
5. Immunohistochemistry 
 
Serologic testing 
 This is the commonest method of non-invasive diagnosis for H.pylori.  
Generally the prevalence of raised IgG in the population tends to be higher in 
developing countries than in developed countries.  Soon after the discovery of 
H.pylori,22,85 Jones et al described a complement fixation test that had an accuracy 
of 80% to 90%.  Alternative methods, such as hemagglutination, were available 
soon after this, followed by more sophisticated enzyme-linked immunosorbent 
assay (ELISA) methods, such as those first described by Good-win et al. 
 The various serodiagnostic techniques used in detecting H.pylori are 
Bacterial agglutination, Complement fixation test, Haem-agglutination, ELISA, 
Western blotting, Co-agglutination, immuno-fluorescence, Radio immunoassay 
and Latex agglutination.80 
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 Sensitivity and specificity of ELISA depend largely on the nature of the 
antigenic materials bound to the solid support. Although more expensive, the gold 
standard for multiple antigens can be obtained in an individual patient. 
 
 In cases in which serologic response has been studied, it appears to be 
similar to any other bacterial infection (i.e., after approximately 14 days, IgM is 
present and by 21 days, IgG is detectable).  IgM declines over the next 3 months 
so that patients with chronic H.pylori infection usually have no IgM but always 
have IgG.  IgA is variable.  The antibody titres preserve their levels even after the 
eradication of the bacteria by antibacterial therapy.  A 50% fall in titer of IgG 
between 6 and 9 months after treatment is predicted as cure. 
 
Urea breath tests 
 This test is based on organism’s urease activity, which liberates carbon 
dioxide (Co2) from urea and produces ammonia to buffer its acidic environment.  
Ingestion of labeled urea results in the production of labeled CO2, which then can 
be detected in the breath.  In contrast to antibody based testing, the urea breath test 
identifies patients with active H.pylori infection85. 
 Two forms of labeled urea are available: one contains the stable, 
nonradioactive isotopes 13C, and the other contains the radioactive isotope 14C.  
Because of broad exposure of ingested 14C-urea to the gastric mucosa, sampling 
error theoretically is less of a problem with the urea breath test than with the 
biopsy based diagnostic methods for H.pylori. 
Stool tests 
 Culture of H.pylori has been obtained from stool samples, but viable 
organisms are present only in a small percentage of cases.  An enzymatic 
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immunoassay that detects the presence of H.pylori antigen in stool specimen is 
also available. The test uses polyclonal anti-H.pylori capture antibody absorbed to 
microwells.  The HpSA(Helicobacter pylori Stool Antigen) test has received 
approval from the US Food and Drug Administration for two indications: 
Diagnosis of H.pylori infection in symptomatic adults and monitoring response, 
post therapy in adults 60. 
 
Urease test 
 With the observation that H.pylori was a strong urease producer, several 
groups began to work on the use of urease as a marker of H.pylori in the human 
stomach.  This work ultimately resulted in the rapid urease test and the urea breath 
test, both are now widely used in the diagnosis of this common infection.60 
 The enzyme was active at physiologic temperatures, with an optimum of 
45oC.  The enzyme was found to be rapidly denatured in acid, so that it was 
inactive at any pH less than 4.5. Active urease is located only beneath the mucus 
layer where the pH is neutral and the H.pylori organism resides.  Urease tests can 
be based on biopsy or can be performed on samples of gastric mucus scraped and 
retrieved from the stomach at endoscopy. 
 False positive results may occur when non-H.pylori helicobacter 
organisms infect the gastric mucosa.  Helicobacter heilmannii is also urease 
positive.  Urease reactions are less intense with non-H.pylori helicobacer 
organisms and are more likely to be positive in the corpus rather than in the antral 
mucosa. 
 Patients taking omeprazole often have achlorhydria.  Subsequent 
superficial colonization of the gastric mucus layer with urease producing 
organisms (e.g., Proteus mirabilis or Klebsiella) can give a false-positive urease 
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test after 24 hrs of inoculation but generally are negative when the test is read 1 
hour after biopsy insertion. 
 The presence of achlorhydria causes false-negative urease test results 
because the luminal pH of 7.0 can lead to an extremely high pH adjacent to the 
organism such that H.pylori is destroyed by the action of its own urease. 
 
Biopsy 
 The bacteria are an important part of the histopathology of H.pylori 
gastritis.  Bacterial stains for histology must contrast the organisms against the 
complex background of tissue section.  The position of H.pylori on the surface of 
mucus-secreting cells, makes histological staining a little easier.  The method 
must stain the organism and not the mucus. 
 Commonly used special stains include Warthin-Starry, Giemsa, Diff-Quik, 
Genta and El-Zimaity’s triple stain.  The Warthin-Starry method stains the 
bacteria black and shows them well.  A simplified version of the Giemsa stain 
works well.  The stain  should be heated for a short time.  One should adjust the 
time to stain the Helicobacter and not the mucus, using a positive control slide.  
This method destroys the color balance expected with Giemsa but not required for 
bacteria.  The bacteria stain blue with a white or pale blue background. 
 The contrast between the bacteria and background tissue is greatest with 
the Genta stain.  In contrast, gastric morphology is better with El-Zimaity’s triple 
stain. The Diff-Quik, an inexpensive histologic, stain, has excellent sensitivity and 
specificity.16 
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 For the detection of scant number of organisms, immunohistochemistry 
22,51 proved to be highly specific and sensitive and superior to conventional 
histochemical methods. 
 IHC for detection of H.pylori in gastric biopsies has also been shown to 
improve the rate of identification of the organisms after treatment when histologic 
examination and cultures were negative. 
Histologic evaluation has traditionally been the gold-standard method for 
diagnosing H.pylori infection.80,90 The disadvantage of this technique is the need 
for endoscopy to obtain tissue. Limitations also arise at times because of an 
inadequate number of biopsy specimens obtained or failure to obtain specimens 
from different areas of the stomach. In some cases, different staining techniques 
may be necessary, which can involve longer processing times and higher costs. 
However, histologic sampling does allow for definitive diagnosis of infection, as 
well as of the degree of inflammation or metaplasia and the presence / absence of 
MALT lymphoma or other gastric cancers in high-risk patients. 70,82    
 Apart from graded variables describes in the updated revised Sydney 
system, special attention has been thrown on non-graded variables like surface 
epithelial changes, mucin depletion, erosions, lymphoid follicles, cells drop out, 
foveolar hyperplasia, pseudopyloric metaplasia and endocrine hyperplasia.82 
 The recent article states that emerging therapies, including development of 
a vaccine that may enable the future eradication of the organism as a significant 
human pathogen. 3 
 
Polymerase chain reaction 
 The application of polymerase chain reaction (PCR) with respect to 
H.pylori is useful for molecular epidemiologic aspects as well as for detection 
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purposes. PCR can be used to distinguish between strains of H.pylori and in 
typing and determining reinfections. Current detection methods by PCR 12,14,66,85 
are aimed at detecting H.pylori in clinical samples collected by less invasive 
means, such as gastric juice, saliva, dental plaque, and faeces. 
 
TREATMENT 
 Cure of H.pylori infection is not easy and requires combinations of 
antibiotics often with additional non-antibiotic adjunctive agents. 
Recommended regimens to treat H.pylori infection 
Bismuth triple therapy 
 Bismuth two tablets four times daily 
 Metronidazole 250mg four times daily 
 Tetracyclin 500mg four times daily 
Proton pump inhibitor (PPI) triple therapy 
 PPI twice daily  
 Amoxicillin 1000mg twice daily (or) 
 Clarithromycin 500mg twice daily 
Quadruple therapy 
 PPI twice daily  
 Bismuth two tablets three or four times daily. 
 Metronodazole 500mg three or four times daily. 
 Tetracyclin 500mg three or four times daily. 
 The most effective regimens to cure H.pylori infection are combinations of 
two antibiotics and adjunctive agents taken for 14 days.3,85,88 
 
 33
 The most effective and best tolerated combination seems to be twice-a-day 
combination of 1000mg of amoxicillin and 500mg of clarithromycin [PPI + AC] 
or 500mg of metronidazole and either 250 or 500mg of clarithromycin [PPI + 
MC]. 
Quadruple therapy 
 The triple therapy is often sufficient unless the organism being treated is 
resistant to clarithromycin or metronidazole.  One regimen that provides effective 
eradication of H.pylori in either instance is high dose quadruple therapy. 
Definition of cure 
It is defined, as absence of the organism by tests performed no sooner 
than four weeks after cessation of antimicrobial therapy. 
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MATERIALS AND METHODS 
 
 In the present study, endoscopic biopsies were taken from 50 patients, who 
attended gastro enterology department with complaints of nausea, vomiting, 
dyspepsia, flatulence and fullness were screened with detailed clinical history 
regarding socio-economics status, housing conditions, water supply etc. 
After thorough clinical evaluation, patients suspected to have gastric 
lesions were subjected to endoscopic biopsy procedure. 
 Methodology  
Endoscopy 
¾ Upper gastro – intestinal endoscopy was performed with flexible fiber optic 
endoscope manufactured by Pentax model number 29P. 
¾ Informed consent was obtained from patients. Relevant history and clinical 
details were recorded. 
¾ After overnight fasting, endoscopy was done on the following morning, 
endoscopic changes were noted in esophagus, stomach, duodenum were        
recorded.  
¾ Three gastric biopsy specimens were taken from antrum and corpus and one 
was immediately used for Rapid Urease test (Annexure I) and the other was 
immediately fixed in 10% buffered neutral formalin for histopathological 
evaluation. 
 
Histopathologic study of biopsy Specimens 
 The biopsy specimens that were fixed in 10% buffered neutral formalin 
were processed in automatic tissue processor for paraffin embedding, then 3-5 μ 
sections were cut.  
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 The sections were stained with Haematoxylin & Eosin (Annexure II) for 
evaluation of histopathological features and special stains like Giemsa and Alcian 
Blue / PAS stain (Annexure III) used to detect H.pylori organisms. 
 Gastritis was defined and classified according to established histological 
criteria with revised updated Sydney system. 
The density of H.pylori, chronic inflammation, neutrophil polymorphic 
activity, glandular atrophy and intestinal metaplasia were recorded in all cases of 
gastritis and graded as mild, moderate and marked scale according to the 
guidelines provided by the updated revised Sydney system, using the visual 
analogue scale. The most prevalent appearance on each slide was matched with 
the graded panel that resembles it most closely. Lesion being active was signified 
by presence of neutrophils within glandular and surface epithelial layer. Glandular 
atrophy was identified, when gastric glands were correspondingly decreased in 
amount and widely separated. An increase in lymphocytes and plasma cells in 
lamina propria categorizes the gastritis as chronic. Infiltration involving upto 1/3 
of gastric pits and surface are designated as mild between ½ to 2/3 as moderate 
and more than this as severe gastritis.  
 Apart from graded variables described in the updated revised Sydney 
system, special attention has been thrown on non-graded variables like surface 
epithelial changes, mucin depletion, erosions, lymphoid follicles, cells drop out, 
foveolar hyperplasia, pseudopyloric metaplasia and endocrine hyperplasia. 
 In addition, the recent literature regarding epidemiology, clinical features 
pathogenesis and pathology of H.pylori infection were also reviewed. 
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OBSERVATIONS AND RESULTS 
 This study covered 50 patients clinically suspected to have gastritis and 
undergone upper-gastro intestinal endoscopy. In the 50 cases, 35 were males with 
age ranging from 20 years to 70 years (mean age 45 years) 15 were females with 
age ranging from 20 years to 60 years (mean age 40 years). 
 When the patients were divided into 6 groups according to their age      
(< 20, 21 – 30, 31 – 40, 41 – 50, 51 – 60, 61 – 70) there was significant increase in 
the Helicobacter pylori (H.pylori) positivity in the age group of 41 – 50 years 
(53.8%) followed by 31 – 40 years (50.0%). Table - 1 
S.No Age (in Years) Total no. of cases 
H.pylori Positive 
Cases Percentage 
1 Below 20 4 1 25.0% 
2 21 – 30 6 2 33.3 % 
3 31 – 40 20 10 50.0 % 
4 41 – 50 13 7 53.8 % 
5 51 – 60 5 1 20.0 % 
6 61 – 70 2 1 50.0 % 
 Total 50 22 44.0  % 
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The clinical presentations of the patients are summarized in the following table. 
Table-2 
S.No Clinical Presentation No. of Patients Percentage 
1. 
Upper abdominal pain, Bloating 
sensation, Belching (dyspepsia) more 
than 3 months 
41 82 % 
2. Abdominal discomfort with Vomiting, Nausea 18 36 % 
3. Epigastric Pain + Malena + Heart burn 6 12 % 
4. Epigastric Pain + Haematomesis 4 8 % 
5. Post cibal abdominal distension + Loss of appetite + Iron deficiency anemia 12 24 % 
 
 Abdominal pain with dyspepsia more than 3 months is the commonest 
clinical presentation followed by abdominal discomfort with vomiting and nausea. 
Abdominal discomfort with anemia was noticed in some cases. 
 Majority of the patients belonged to lower socio-economic status who used 
un-hygienic water and lived in over crowded surroundings. 
 38
 
Endoscopic Examination       
 Detailed endoscopic findings in all the 50 cases are listed in Table-3.  
 
Table-3  
S.No Endoscopic diagnosis No. of Patients Percentage 
1 Gastric ulcer < 2cm with erosion and edema 12 24 % 
2 Antral gastritis with duodenal ulcer 12 24 % 
3 Nodularity of gastric mucosa 5 10 % 
4 Patchy erythematous gastric mucosa 6 12 % 
5 Duodenal erosion with edema 5 10 % 
6 Unremarkable mucosa 10 20 % 
 
 
 Upper gastro-intestinal endoscopy revealed 12 cases showed gastric ulcer 
ranging from 0.5 cm to 2 cm with erosion and edema; 12 cases antral gastritis with 
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duodenal ulcer; 5 cases showed nodularity of gastric mucosa; 6 cases with patchy 
erythematous gastric mucosa; 5 cases were with duodenal erosion and edema with 
ulceration ranging from 0.25 cm x 1 cm to 1.5 cm to 3 cm and 10 patients did not 
show any endoscopically detected lesion. Fig.3, 4 
Endoscopic findings and corresponding histopathologic diagnosis of 50 
endoscopic biopsies are listed in the following table (Table-4).       
Table-4 
S.No Endoscopic Feature Histopathological Feature 
1. Gastric Ulcer with erosion – 12 
Chronic Active antral gastritis –10 
with surface epithelilal changes 
Normal mucosa – 2  
2. Antral gastritis with duodenal ulcer – 12 
Chronic mild gastritis  – 8 
Atrophic gastritis - 2 
Chronic active gastritis – 2 
3. Nodularity of gastri mucosa – 5 
Chronic active antral gastritis  – 3 
Chronic gastritis with Intestinal 
Metaplasia  - 2 
4. Patchy erythematous changes –6   Chronic mild gastritis  – 1 Chronic active antral gastritis  – 5 
5. Gastric Ulcer Duodenitis – 5 
Chronic mild gastritis  – 2 
Chronic gastritis with Intestinal 
Metaplasia  - 3 
6. Unremarkable mucosa - 10 
Normal mucosa – 8 
Chronic mild gastritis – 1 
Chronic active antral gastritis  – 1 
 
 In 10 cases, where endoscopy was normal, there was histological evidence 
of chronic active gastritis in one case and mild gastritis in one case and eight cases 
shows normal gastric mucosa. These shows an apparent lack of correlation 
between endoscopic and Histopathalogical diagnosis of gastritis in dyspeptic 
patients. 
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RAPID UREASE TEST (RUT):  
 RUT for detection of H.pylori from endoscopic specimen. 
The biopsy specimen was subjected to Urease testing in 50 cases, of which 
there were 24 positive cases. Among the 24 Urease positive cases, 22 cases were 
detected Histopathologically for H.pylori. 
 In the 26 Urease negative gastritis biopsy, Giemsa staining also did not 
detect H.pylori. 
 RUT is a simple, cheap test, performed at endoscopy room itself using 
Helicheck test device. It contains urea solution with indicator that detects 
alkalinity resulting from formation of ammonia in most infected patients (70%) 
and gives positive result within 2 Hours. In cases of positive result, it shows a 
change in colour from yellow/orange to pink/ red. Whereas, in cases of negative 
result, the colour remains as yellow colour itself. Urease test detects upto 0.3 unit 
of urease present in sample Fig.5 
 
Limitations of this test  
1. The test is pH sensitive and therefore, any contamination in the reaction 
wells will change the reaction. 
2. Biopsy specimen collected in preservatives with acidic or basic pH such as 
formalin etc should not be used for Heli-Check RUT test device. 
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Histopathological diagnosis of H.pylori 
     
 Though the H.pylori organisms were visible in the H&E stain, 
demonstration by Giemsa stain is considered as the gold standard for H.pylori 
detection. It facilitates the identification of H.pylori by darkening the 
organism.Fig. 11 
 Using Giemsa stain, the spiral shaped bacteria of H.pylori is attached to 
brush borders of gastric foveolar cells and inside the gastric pits (Luminal side of 
gastric mucosa). The distribution was mostly patchy and single. Lying close to 
surface epithelium and more densely distributed within lumen of gastric pits. It 
also extends less into the deeper portion of the mucosa. The organisms are absent 
in the areas of intestinal metaplasia. 
  
In this present study, H.pylori was demonstrated by using Giemsa stain in 
22 out of 50 biopsies. 
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Table 5 
S.No Procedure Diagnosis No. of patients 
1. Endoscopy (N = 50) 
1. Patchy erythematous changes 6 
2. Antral gastritis with D.ulcer 12 
3. Nodularity of gastric mucosa 5 
4. Gastric ulcer with erosion 12 
5. Unremarkable mucosa 10 
6. Duodenitis 5 
2. Giemsa staining (N = 50) 
H.pylori Positive 22 
H.pylori Negative 28 
3. Urease testing (N = 50) 
Positive Urease test 24 
Negative Urease test 26 
         
 Endoscopy  Giemsa staining Rapid Urease test
Patchy erythematous Antral gastris ulcer mucosa
erosion Mucosa Duodenitis
positive negative Posi. Urease test
Nega. Urease test
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Association between Gastritis & presence of H.pylori 
 Most of the biopsy specimen, which were positive for H.pylori showed 
histological evidence of Gastritis  
 Twenty-four cases showed chronic active antral gastritis and activity 
implying the presence of high number of Neutrophilic polymorphs in the lamina 
propria and within epithelium. 
Relationship between H.pylori density and severity of Gastritis: 
 There was no correlation between the degree of inflammation, noted in the 
histolopathologic study and density of H.pylori organisms. 
Histopathology of gastric antral biopsies: 
 The presence or absence of H.pylori with varying degree of chronic 
inflammation, Neutrophilic polymorphic activity, glandular atrophy, intestinal 
metaplasia and gastric surface epithelial changes were recorded in 50 cases. When 
present, each of these variables was graded on a mild, moderate or severe scale as 
indicated by the updated Sydney system. 
 The following table (Table 6) shows details of histopathological findings 
of all the 50 gastric biopsies. Out of the 50 cases, only 22 cases show gastritis with 
H.pylori positive. 
 Histopathologically 10 cases (20%) showed evidence of normal gastric 
mucosa of which 2 cases (20%) were H.pylori positive. The remaining 40 cases 
(80%) showed evidence of H.pylori infection with chronic antral gastritis. Out of 
40 cases 24 cases (66.67%) showed evidence of chronic active gastritis, of which 
16 cases were H.pylori positive. Among the remaining 16 cases, 9 cases (18%) 
showed chronic non-active gastritis of which 4 cases (44.3%) were H.pylori 
positive; 5 cases (10%) were detected with Intestinal metaplasia and 2 cases (4%) 
were detected with atrophy. 
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Histopathological findings of endoscopic gastric biopsy 
Table 6 
S.No Histopathology No. of cases Percentage 
H.pylori 
Status 
H.pylori 
% 
1.  Normal gastric mucosa 10 20 % 2 positive  11 negative  20 % 
2. 
H.pylori associated 
chronic active antral 
gastritis (CAAG) 
24 48% 16 positive 8 negative 66.6% 
3. 
H.pylori associated 
chronic non active 
gastritis (mild)  
9 18% 4 positive  17 negative  44.3% 
4. Chronic gastritis with atrophy 2 4% All Negative  0% 
5. Chronic gastritis with intestinal metaplasia 5 10% All Negative 0% 
6. 
H.pylori Negative 
chronic non active 
gastritis 
28 76% All Negative 0% 
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Histopathology of H.pylori associated gastritis: 
Chronic mild gastritis 
 Inflammatory infiltrate is limited to the foveolar region and 
unaccompanied by glandular atrophy. Epithelial abnormalities like reduced 
amount of cytoplasmic Mucin and cells with enlargement of nuclei and slightly 
increased mitosis in foveolar epithelium. 
 In the early phases chronic mild gastritis inflammatory infiltrate of 
lymphocytes and plasma cells is typically present within the lamina propria, usually 
limited to the upper third of the gastric mucosa(Superficial location).Fig. 17 
Chronic active gastritis:  
• Mucosa shows dense infiltrate of chronic inflammatory cells in which 
plasma cells are predominant in lamina propria, and also involve full 
thickness of mucosa. It may surround and separate the glands without 
causing atrophy. Fig. 18 19 
• Lymphoid follicules with germinal centers in deeper portion of mucosa. 
Fig. 20 21    
• Surface and foveolar epithelium infiltrated by neutrophils, which is 
predominant, termed as “Pit abscess” in which H.pylori organisms are 
readily identified. Fig. 22 
• Other surface epithelial changes like degeneration, regeneration with 
variable erosions, Neutrophil reaction in lamina propria and epithelial 
layer. Occasionally epithelial changes like irregular ragged surface; 
epithelial pits; individual cell dropouts; micro erosions can also occur. 
Mucosal changes like erosion and ulcerations are seen. Fig. 13 14 19 
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In the present study, 5 cases of Intestinal Metaplasia and 2 cases of Chronic 
gastritis with atrophy were identified in the Histopathological examination. 
 
Chronic atrophic gastritis: When inflammation is more extensive and 
accompanied by glandular atrophy the condition is termed as chronic atrophic 
gastritis. It is classified as mild, moderate and severe atrophy as per graded 
variable in updated Sydney system. Fig. 12 21 
  Glandular atrophy is characterized by increased distance between 
individual glands and condensation of retilculine fibres in lamina propria.  Mucosa 
shows more obviously thinned and flattened, with extension of infiltrate in the 
lamina propria to deeper layer. There is often atrophy of glands (loss of gastric 
glands) fibrosis and variety of cytology changes in the surface epithelial cells.  
 Intestinal Metaplasia (IM): Is defined as a progressive replacement of 
gastric mucosa by intestinal epithelium. Either small or large bowl type including 
goblet cells absorptive (brush border cells), paneth cells, variety of endocrine 
cells, ciliated cells are also present. IM is classified into complete Type I, 
incomplete Type II and Type III. This is based on morphological features and 
mucin content of goblet & columnar cells. Fig.9 10 20 
IM - Type 1 Complete – Type I metaplasia gastric mucosa is changed to 
pattern nearly identical to that of small bowl epithelium, reveals numerous 
columnar absorptive cells, few goblet mucous cells which secrete mildly acidic 
mucins such as sialomucins. This subtype has lower cancer risk Fig 20.        
 IM Type incomplete - Type II IM absorptive cells are absent and consist 
a mixture of gastric foveolar and colonic type goblet mucous cells. Both mucous 
cells contain highly acidic mucins such as sialomucins and neutral mucin. 
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  IM Type III - IM characterized by columnar cells that secrete sulfomucin 
– differentiated from sialomucin by staining with high iron diamine.  
 IM carries an approximately 10 fold increased risk for development of 
gastric cancer.  
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DISCUSSION 
 Considering the percentage of morbidity and mortality caused by various 
gastric lesions and high prevalence of H.pylori infection, extent of their 
association is gaining importance. 
 The most impressive advance has come from the flexible fibroscope with 
which it is possible to examine esophagus, stomach and duodenum, and at the 
same time biopsies for Histopathological Examination can be obtained. 
 Infection with H.pylori is worldwide chronic infection with the highest 
incidence in developing countries.91 It is associated with duodenal ulcer, chronic 
active gastritis, gastric cancer and gastric lymphoma, which can be easily 
identified by endoscopic gastric biopsy. 
 Chronic gastritis is defined as the presence of chronic mucosal 
inflammatory changes eventually leading to mucosal atrophy 28 & epithelial 
metaplasia. By far the most important etiological association is chronic infection 
by the bacillius H.pylori.92 The organism is a world wide Pathogen that has the 
highest infection rates in developing countries.42,77 
 
Sex distribution 
 Age and sex related possibility of H.pylori was studied. In the present 
study, out of 35 male cases 16 cases (45%) are positive for H.pylori and out of 15 
female 6 cases (40%) are positive for H.pylori. The male to female ratio is 2:1 
which is in contrast to the study literature and study conducted by Abdur Rauf 
Khan 2 
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Age distribution:  
The higher prevalence of H.pylori is in the age group of 41-50 years, 
which had highest percentage (53.8%) and followed by the age group 31-40 years 
(50.0%) This is in consonance with Richard,Freferick J81 who states that 
prevalence of H.pylori increased with advanced age. Anderson states that the 
prevalence of H.pylori in adults approximates 100% in many developing tropical 
countries.   
 The prevalence of H.Pylori in the present study is 44%. It does not 
coincide with study of Abdul Rahman E, Fakhro1 et al.,, In their study the 
prevalence rates are 79.4%. 
 This high percentage may be due to low socio economic status of the 
patient and lack of education about hygiene in most of those people. This 
accordance with James Fox at la49 Dube C :N F Tanih at al13 stated that H.pylori 
spreads from person to person and via a route that depends on hygiene proved by 
several studies. 
 In the present study, 45 cases out of 50 shows dyspepsia, abdominal pain, 
iron deficiency anemia.41,78 These are the most common symptoms encounter in 
other studies also. 
Perusal of literature shows epigastric pain, which is the most common 
symptom (92%) followed by vomiting (51%) and hematemesis (17%) in H.pylori 
associated chronic gastritis. 
In the present study epigastric pain was present in most cases (92%) 
followed by vomiting (36%) and haematemesis (8%).        
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 As per study done by Graham 36Gill Desai etal 34 who revealed that 
geographic and social patterns play a role in transmission of H.pylori. According 
to Anderson, East Asian countries where wide spread sanitation has been 
introduced, prevalence of H.pylori has shown downward trend.  
 Transmission from patient to patient after endoscopy has also been 
described.  
 As per study the high percentage of H.pylori positive individuals having 
gastric lesions were found to have history of intake of spicy and non-vegetarian 
food. H.Pylori infection highly frequent in dyspeptic patients, and it is cardinal 
risk factor for chronic gastritis.7 
 
Endoscopic features:  
The advent of the fiber optic gastroscope with biopsy facilities has 
provided the means of obtaining biopsy specimens under direct vision from any 
part of stomach.73 
In this present study, there were 12 cases gastric ulcer with erosion, out of 
which 8 cases (66%) were positive for H.Pylori and  12 cases of duodenal ulcer in 
which 9 cases were positive (70%) and small proportion of cases showing patchy 
erythematous changes, nodularity of gastric mucosa46 and of unremarkable 
mucosa were also found  in endoscopy examination.  
 Normal looking gastric mucosa is commonest single endoscopic finding, 
accounting for 20% cases. Though the results of endoscopic examination may 
show normal mucosa, 28histopathological examination may show positive for 
H.pylori. In these cases, risk of re-infection is always there94 
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 The positivity rate for duodenal ulcer is 70% and gastric ulcer is 66% in 
our study. It is comparable to study by Tytget 98 (1988) who found that 15 patients 
of duodenal ulcer and 9 out of 11 (81.8%) patients with gastric ulcers have the 
organism. And in 2002 Sengupta et al 86 studied antral biopsy specimens from 25 
patients with symptoms and diagnosis of duodenal ulcer, amongst whom the 
positivity rate is 84%. In a study by Zhang C, Yamada N et al 96 the prevalence of 
H.pylori in gastric ulcer is 80.8%. Duodenal ulcer is usually associated with 
H.pylori infection. Treatment of duodenal ulcer must, therefore include acid 
reduction and H.pylori eradication all the time.  
 The most convincing data implicating H.pylori as a cause of cancer are 
furnished in the case-control studies from Hawaii, California, Great Britain, 
Taiwa55 . In the first three studies (mean follow – up years 13, 14, 6 years 
respectively), serologic evidence of H.pylori infection associated with increased 
risk of developing gastric cancer, is 2.8 to 6 fold. The fourth nested case control 
study also identified an elevated risk of cancer (odds ratio = 1.6) but the finding 
was not statistically significant. This last study was hampered, however by a small 
number of cases, and short follow-up period.  Overall the association between 
H.pylori and cancer appeared to be restricted to tumors distal to gastric cardia. 
 One line of research currently favours H.pylori infection as a causal factor 
in both MALT and non-MALT gastric lymphomas.55           
 When the density of H.pylori is low, application of endoscopic brush 
cytology helps in rapid detection. 4 21 
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Rapid Urease Test (RUT): 
At present, there are at least seven diagnostic assays for H.pylori, 
including bacterial culture, a RUT66 urea breath test, histopathology, Polymerase 
chain Reaction 52, immuno histochemistry using H.pylori antiserum, serology and 
stool antigen test, which is limited when patients are taking acid-suppressing agents 
(proton-pump inhibitors) 
 In the present study, H.pylori is positive in 24 cases (48%) by RUT. It 
more or less correlates with a study done by U. Arora et al 6 who studied 75 
gastric biopsy specimen of same patients complaining of dyspepsia. H.pylori is 
positive in 52 cases (72%) by RUT.  
 Gill et all 33,34 have shown that antibodies to H.pylori in serum are present 
in 80% of Indian subjects with upper G. I. Symptoms. 
 Some of these methods are based on the high urease activity of                     
H.pylori  but because they detect all enzyme activity of urease regardless of its 
origin, there is the possibility that urease derived from other bacterial species, 
such as Proteus mirabilis or Klebsiella Pneumonia will confound the result.  
 Out of 50 cases, 22 were positive on Modified Giemsa stain and 24 
positive for rapid urease test. 22 cases were positive for both rapid urease test and 
Modified Giemsa stain while 2 cases were negative by rapid urease test. Hence 
sensitivity and specificity of modified Giemsa stain in detecting H.Pylori in 
gastric lesions used by us in present study shows sensitivity of 94.2% specificity 
of 96.0% this study conducted by Madan et al 18 who found the percentage of 
H.pylori positivity with modified Giemsa technique was 100%, as per Grey et al 21 
study modified Giemsa stain is simple, reliable, widely used stain. 16 
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False negative test (Modified Giemsa Negative and urease positive) in our study 
could be a result of difficulty in identification of H.pylori. Marshall et al 21 
attributed false positive urease test reaction to contamination of biopsy specimen 
with alkaline bile or growth of other urease-producing bacteria. They proposed 
addition of pH buffer, which enabled to control these factors. They found no false 
positive results even in patients with duodenogastric bile reflux and ingestion of 
milk on evening prior to endoscopy may have enhanced urease contents of 
mucosa. False positive tests could be attributed to low bacterial load. 
 The typical histopathologic appearance of H.pylori gastritis is moderate to 
marked inflammation, as per Tabei M.D et al90 which is immediately recognizable 
at high power.  Sometimes the acute inflammation may be relatively scant in the 
corpus compared to antrum & cardia. 
 The intense acute inflammation will be found in cases, in which the 
H.pylori are most abundant. Most of these cases have numerous organisms at the 
luminal surfaces, which can be quickly identified on the H&E stained slide, The 
haematoxylin and eosin has a high degree of accuracy (98) similar to Giemsa (96) 
and Genta (97) stain.16,80 
  Owen has pointed out that the bacteria can be easily seen on well 
differentiated haematoxylin, and eosin sections. 
Histopathological study (Histopathology): 
 The Recent Implication of H.pylori in the pathogenesis of gastritis-peptic 
ulcer syndrome, and its relevance in development of upper gastro intestinal 
malignancy warrant efficient methods for the detection and demonstration of 
organism in biopsy specimens 51,79,80 
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 A two-way interaction might exist between H.pylori and gastric acid that 
determines pattern of gastritis and hence clinical outcome. 48. 
 The prevalence of H.pylori in the present study is 44%. It is similar to a 
study by Abdul Rahman, E Rakhro et al 1 Histopathologically, 24 cases (48%) 
out of 50 patients, showed evidence of chronic active gastritis and from these 16 
cases (67%) are H.pylori positive. Mild gastritis is evidenced in 9 cases, of which 
4 cases (19%) are H.Pylori positive. 10 cases (20%) are normal gastric mucosa, of 
which 2 cases (40%) are H.pylori positive, 5 cases (10%) of intestinal metaplasia 
and 2 cases (4%) of atrophy are 44,70  detected.  
 Abdul Rahman E Fakhro et al 1studied 102 gastric biopsies in dyspeptic 
patients. In their study, 66 cases (64.7%) out of 102 patients showed evidence of 
chronic active gastritis and from these 65 cases (98.5%) are H.pylori positive, 
Mild gastritis is evidenced in 15 cases (14.7%) of which 9 cases (60%) are 
H.pylori positive. Our present study results are comparable to this study. 
  It is also in consonance with another study done by Bayer Dorffer et al 11 
who found 82.97% cases of chronic active gastritis were positive with H.pylori. 
We conclude that histopathological examination (HPE) is adequate for the 
initial assessment of gastric biopsies.  This is because it is well-tested, cheap, easy 
staining method, requiring a relative short period of time to perform with highly 
reproducible results. It has an added advantage of enabling simultaneous 
assessment of morphological change accompanying H-Pylori infection. 51  
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 In present histopathological study, out of total 50 cases studied, 
histopathological diagnosis of gastritis was reported in 45 cases (80% of cases). 
This is more or less comparable to study done by Wyatt 30  where 90% of patients 
with gastritis showed antral mucosa colonized by H.pylori. 
 As found out in our study Dixon et al 24, stated that neutrophil activity is 
almost universal phenomenon in H.pylori and that neutrophils are very sensitive 
indicator of the presence and absence of H.pylori and they disappear within days 
of cure of infection.  
 If Neutrophils are seen in post treatment biopsy but organisms are not 
apparent, a careful search for H.pylori using one of the special stain should be 
carried out.  
 In present study no cases with intestinal metaplasia was found to be 
positive with H.Pylori. This consonance with study done by steer and Noritaka 
yabulki80    stated that areas of intestinal metaplasia as rule do not contain H.pylori. 
Areas of Intestinal metaplasia indicate the longstanding gastritis and also risk of 
developing gastric carcinoma 80at an early age if left untreated.  
Mucosa associated lymphoid tissue is physiologically absent in normal 
gastric mucosa, but can develop in response to H.pylori infection and it is 
considered to be hallmark of H.pylori infection as a result of chronic antigenic 
stimulation by the organisms. In present study only one case shows gastritis with 
lymphoid aggregates. Acquired mucosa associated lymphoid tissue is considered 
as a precursor of gastric low-grade maltoma. Lymphoid reaction to H.pylori 
infection varies from simple aggregates, follicles with germinal centers to primary 
gastric lymphoma 1,55,88. This study analyzes various lymphoid reactions to  
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H.pylori infection among 50 patients. The study of Stolte et al88 stated that if 
sufficient biopsy specimens are examined, follicular gastritis is found in 100% 
Cases.  H.pylori colonized gastric mucosa shows surface epithelial changes in 
addition to inflammation,80 which include loss of apical mucin, epithelial cell 
dropout, formation of epithelial pits, recognized as irregularities on surface 
epithelium. Changes are mainly seen in pit regions of glands. They are cells which 
shows pleomorphism with  hyperchromatic nuclei,  rarely cellular exfoliation and 
syncytial regenerative changes.  
The Sydney system for the classification of gastritis emphasized the 
importance of combining topographical,11 morphological and etiological 
information in to a scheme that would help to generate reproducible and clinically 
useful diagnoses (Revised Sydney system) 24,82,88 gives guidelines for optimal 
biopsy sampling of the stomach, use of visual analogue scales for grading the 
histopathologic features and formation of comprehensive standardized diagnosis.   
Good evidence exists in the literature that H.pylori can cause chronic 
active gastritis.  Most compelling and direct evidence are studies by Dr. Marshall 
et. al and subsequently by Moris and Nicholson.  In these studies Moris and 
Marshall infected themselves with H.pylori and this led to the development of 
clinical and microscopic gastritis in these subjects and Koch’s postulates of the 
etiology of the disease seemed to be fulfilled. 
As further evidence of pathogenicity, secretory IgA directed against 
H.pylori has been isolated, (3,6-22) and phagocytosis of the organism has been 
shown by intra gastric neutrophil.  Others have successfully eradicated the 
organism with antibiotics, with resultant improvement of histologic gastritis.  
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In the present study, it is found that, more or less the antral biopsies 
colonized by H.pylori, showed evidence of gastritis91, It confirms the previously 
reported high prevalence of H.pylori infection in association with antral gastritis 
further supporting the contention that H.pylori is the etiologic agent of this lesion 
in most cases.  
Helicobacter Pylori is now accepted cause of gastritis and peptic ulcer 
disease in adult.27,29,50,97,98 
The following table shows comparative analysis of various studies in 
children, reporting relationship between H.pylori infection and histological 
evidence of gastritis percentage in adults. This shows 50% of cases of gastritis 
show H.pylori positivity in contrast to the pediatric cases. Probably environmental 
factors, socio economic status, alcohol and smoking modified the development of 
gastritis with typical symptoms in adults.  
S.No Name of the author and year 
H.pylori – 
infection   
(No. of 
cases) 
Histo 
pathological 
gastritis  
(No. of cases) 
% of H.pylori – 
infection 
associated with 
gastric 
inflammation 
1. Musgrove et al75 1988 54 61 88% 
2. Hartley Cohen et al 401989 22 22 100% 
3. Grace W Elta et al35 1989 16 16 100% 
4. Siobhan M Gormally et al871995 19 19 100% 
5. C.K. yeung et  al 1990 64 64 100% 
6. Present study 2010 22 45 50% 
 
 
According to Dixon degree of chronic inflammatory cell infiltration is 
correlated to the extent and density of H.pylori colonization. But we couldn’t find 
 58
significant correlation between these two factors and the differences can be 
explained 90as follows:- 
1. Difference immunological as well as histological responses in various age 
groups, could be due to genetic, social cultural economical, psychological 
factors.90 
2. Some patients may have chronic inflammation (gastritis due to other 
causes and H.pylori, infection) simultaneously. 
3. Partially treated patient may show lower degrees of inflammation. 
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CONCLUSION 
 Helicobacter pylori is now widely recognised as the most common cause 
of primary or unexplained gastritis in adults as well as children. 
 
 The present prospective study of 50 patients presenting with the upper 
abdominal pain, dyspepsia were undertaken to evaluate the relationship of this 
symptom complex to inflammatory gastroduodenal lesions with special reference 
to H.pylori infection. The clinical and endoscopic findings, Rapid Urease test and 
histopathological examination of gastric antral biopsy material were all evaluated 
and the following conclusions are presented. 
           
(1) A positive significant association between abdominal pain and H.pylori 
gastritis. It was identified in 44% cases and recurrent epigastric pain was 
the commonest presenting symptom. 
(2) As mentioned in the literature, H.pylori infection can occur in childhood 
and common in adult of low socio-economic status in poor hygienic living 
conditions, consuming unhygienic food and drinking water. 
(3) In the present study, as in the studies of many others, it was found that 
H.pylori colonization of gastric mucosa was always associated with 
chronic gastritis and further supporting the correlation that H.pylori 
organism is the etiologic agent of this lesion in most cases. H.pylori 
organisms were also seen in 2 cases with normal mucosa. 
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(4) In addition, 12 cases were diagnosed by endoscopy to have duodenal ulcer, 
also had H.pylori antral gastritis. According to literature, duodenal ulcer 
disease in adults is strongly associated with the presence of H.pylori on 
antral mucosa. 
(5) There was no correlation seen between severity and degree of 
inflammation and the density of H.pylori organisms. 
(6) Common pattern of inflammation consists of mononuclear cell and 
neutrophils. Polymorpho Neutrophilic activity is almost a universal 
phenomenon in H.pylori gastritis.    
(7) Significant number of antral biopsies in H.pylori gastritis showed focal 
lymphonodular hyperplasia, which is considered to be a hallmark in this 
diagnosis and also said to be unique to paediatric and adult H.pylori 
infection. 
(8) The surface epithelial changes of antral mucosa viz loss of apical mucin, 
cell drop out, formation of epithelial pits which are considered specific for 
H.pylori colonization were seen in all cases of H.pylori gastritis. The 
presence of epithelial changes may be used to screen more carefully for 
H.pylori in a given biopsy if organism is not apparent. 
(9) There was a poor correlation between endoscopic findings and presence of 
histological gastritis, showing that a diagnosis of gastritis cannot be readily 
excluded in the absence of gastric biopsy. 
(10) There was excellent correlation between Urease test and H.pylori 
gastritis.  
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(11) Recent article states that there is an emerging therapy in development of 
vaccine that may enable the future eradication of the organism. 
(12) A “test and treat” strategy is recommended for most patients with 
undifferentiated dyspepsia.With this approach, patients undergo a 
noninvasive test for H.pylori infection and if positive, are treated with 
eradication therapy. This strategy reduces the need for antisecretory 
medications as well as the number of endoscopies. Recently one day drug 
regimen is used instead of two weeks course of medication in H.pylori 
eradication 
(13) As per updated Sydney system published (in October 1996) semi 
quantitative scoring system of gastritis remains a useful tool for clinical 
research. The methods proposed is both feasible and practical when 
satisfactory set of gastric biopsy is available. Staging and grading of 
gastritis could represent the concluding message of the histopathological 
report and also provide useful information about cancer risk.    
 
 1
ANNEXURE I 
RAPID UREASE TEST (RUT) 
1. Rapid urease test  for detection of H.pylori from endoscopic gastric 
specimen. 
2. This is a cheap simple test using Helicheck test device. 
3. It contains urea solution with indicator that detects alkalinity resulting from 
the formation of Ammonia. 
4. The positive result shows yellow to pink within 2 hours, maximum 18 to 24 
hours 
5. Urease test detect upto 0.3 unit of Urease present in sample. 
Limitations of this test  
1. The test is pH sensitive and therefore, any contamination in the reaction wells 
will change the reaction. 
2. Biopsy specimen collected in preservatives with acidic or basic pH such as 
formalin etc should not be used for Heli-Check RUT test device.  
 ANNEXURE II 
H & E STAIN  
1. Sections to water  
2. Stain with Ehrlich’s hematoxylin solution for 30 minutes 
3. Wash briefly in water and differentiate in 1% acid alcohol 
4. Wash well in water and blue for 10 to 30 seconds 
5. Wash in water and stain with 1% eosin solution for 30 seconds to 1 
minute 
6. Wash quickly in water, differentiate and dehydrate in alcohol. Clear 
and mount. 
 
 
 
 
 
 
 
 
 
 
 
 
 ANNEXURE III 
GIEMSA STAIN  
1. Bring sections down to water through graded alcohols 
2. Rinse in pH 6.8 buffered distilled water  
3. Stain in working Giemsa stain for 20 to 30 minutes 
4. Rinse in distilled water 
5. Rinse in 0.5 % aqueous acetic acid until section is pink 
6. Wash in tap water 
7. Blot until almost dry 
8. Dehydrate rapidly   
RESULT 
Organisms – dark blue 
Back ground – pink or pale blue 
 
ALCIAN BLUE / PAS STAIN 
PURPOSE 
To differentiate between neutral and acid mucosubstances 
PRINCIPLE  
Acidic mucosubstances are stained by Alcian blue technique and neutral 
mucosubstances are stained by PAS reaction 
 
 
 PROCEDURE  
1. Deparaffinize the sections and bring to water  
2. Stain the sections in Alcian blue for 5 minutes 
3. Wash the sections in distilled water 
4. Place the sections in 0.5% Periodic acid for 10 minutes 
5. Wash the sections in running tap water for 5 minutes and rinse in 
distilled water 
6. Place the sections in Schiff reagent for 15 minutes 
7. Wash the sections in distilled water and running tap water for 10 
minutes 
8. Stain the sections with Harris hematoxylin containing acetic acid 
for 5 minutes, differentiate as appropriate blue. 
9. Wash the sections in distilled water 5 to 10 minutes. 
10. Rinse in absolute alcohol 
11. Clear in Xylene and mount as desired 
RESULT 
Acid mucin - blue 
Neutral mucin - magenta        
 ANNEXURE III 
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S.No Biopsy Number Age/Sex Endoscopic feature 
Histopathological 
features 
GIEMSA 
staining for 
Hp 
Rapid 
Urease 
test 
1 2723/09 45 Female 
Patchy erythematous 
changes of  gastric 
mucosa 
Chronic active gastritis 
with H.pylori Positive Positive 
2 2718/09 48 Male 
Antral Gastritis with 
Duodenal ulcer 
Chronic active Antral 
Gastritis Positive Positive 
3 1619/10 36 Male unremarkable Mucosa Chronic atropic Gastritis Negative Negative 
4 1641/10 22 Male Gastric ulcer Chronic Active Gastritis Positive Positive 
5 1617/10 45 Male Gastric ulcer Chronic Active Gastritis Positive Positive 
6 1618/10 45 Female unremarkable Mucosa Normal Gastric mucosa Negative Negative 
7 1827/10 28 Male 
Antral Gastritis 
Duodenal ulcer Chronic Active Gastritis Positive Positive 
8 271/10 40 Female unremarkable Mucosa Normal Gastric Mucosa Negative Negative 
9 1529/10 36 Male Duodenitis 
Chronic  Gastritis with 
intestinal metaplasia Negative Negative 
10 2085/10 36 Male 
Antral Gastritis with 
Duodenal ulcer Chronic Active Gastritis Positive Positive 
 
 
S.No Biopsy Number Age/Sex Endoscopic feature 
Histopathological 
features 
GIEMSA 
staining for 
Hp 
Rapid 
Urease 
test 
11 97/09 45 Female 
Patchy erythematous 
changes of  Normal 
mucosa 
Normal Gastric mucosa Positive Positive 
12 46/09 70 Male Duodenal ulcer Chronic mild Gastritis Negative Negative 
13 1810/10 42 Female Gastric ulcer Chronic Active Gastritis Positive Positive 
14 1621/10 45 Female Gastric ulcer 
Chronic Active Gastritis 
with IM Negative  Negative 
15 1800/10 38 Male Duodenal ulcer Chronic Active Gastritis Positive Positive 
16 1956/10  60 Male unremarkable mucosa Normal Gastric Mucosa Positive Positive 
17 2181/10 41 Male Gastritis ulcer Chronic Active Gastritis Positive Positive 
18 2496/10 28 Female Duodenitis 
Chronic Gastritis with 
intestinal metaplasia Negative Negative 
19 1641/10 20 Male Gastric ulcer Chronic Active Gastritis Positive Positive 
20 348/09 46 Male 
Nodularity of Gastric 
mucosa Chronic mild gastritis Negative Negative 
21 1960/10 55 Male Duodenal Ulcer Chronic active Gastritis Positive Positive 
S.No Biopsy Number Age/Sex Endoscopic feature 
Histopathological 
features 
GIEMSA 
staining for 
Hp 
Rapid 
Urease 
test 
22. 653/10 55/Male Unremarkable mucosa Chronic active gastritis Negative Negative 
23. 1959/10 45/Female Gastric ulcer Chronic mild gastritis Positive Positive 
24. 1799/10 37/Male 
Patchy erthematous 
Changes of gastric 
mucosa
Chronic active gastritis Negative Negative 
25. 3309/10 40/Male 
Patchy erthematous 
Changes of gastric 
mucosa
Chronic mild gastritis Positive Positive 
26 3623/10 40/Male Antral gastritis with Duodenal ulcer  
Chronic mild gastritis  Negative Negative 
27. 2420/08 38/Male 
Patchy erthematous 
Changes of gastric 
mucosa 
Chronic active  gastritis Negative Negative 
28. 2145/10 22/Female Gastric ulcer Chronic active gastritis Negative Negative 
29. 2179/10 40/Female  Duodenal ulcer Chronic active gastritis Positive Positive 
30. 1595/10 20/Male Nodularity of mucosa Normal Gastric mucosa Negative Negative 
 
 
 
 
 
S.No Biopsy Number Age/Sex Endoscopic feature 
Histopathological 
features 
GIEMSA 
staining for 
Hp 
Rapid 
Urease 
test 
31. 763/09 54/Male 
Antral gastritis with 
Duodenal ulcer 
Chronic mild gastritis Positive Positive 
32. 2489/09 32/Male Unremarkable mucosa Chronic active gastritis Positive Positive 
33. 1530/10 36/Female Duodenitis Normal gastritis mucosa Negative Negative 
34. 260/10 28/Female Gastric ulcer Chronic active gastritis Negative Negative 
35. 657/09 58/Male Unremarkable mucosa Normal gastric mucosa Negative Negative 
36. 925/09 35/Female Nodularity of mucosa Chronic mild gastritis Negative Negative 
37. 1544/10 33/Male Nodularity of mucosa Chronic active gastritis  Negative Negative 
38. 3182/10 48/Male 
Antral gastritis with 
Duodenal ulcer 
Chronic atrophic gastritis Negative Negative 
39. 2573/08 32/Female Unremarkable mucosa Chronic active gastritis Negative Negative 
40. 150/09 42/Male Gastric ulcer 
Chronic Gastritis with 
intestinal metaplasia 
Negative Negative 
41. 1423/09 38/Male Duodenal ulcer Chronic active gastritis Negative Negative 
S.No Biopsy 
Number 
Age/Sex Endoscopic feature Histopathological 
features 
GIEMSA 
staining for 
Hp 
Rapid 
Urease 
test 
42. 2144/10 20/Male Unremarkable mucosa Chronic mild gastritis Negative Negative 
43 2143/10 55/Female 
Patchy erthematous 
Changes of gastric 
mucosa 
Chronic mild gastritis Negative Positive 
44. 1528/10 37/Male Unremarkable mucosa Normal Gastric mucosa Negative Negative 
45. 2926/09 68/Male Gastric ulcer Chronic active gastritis Positive Positive 
46. 767/10 35/Male Nodularity of mucosa Chronic mild gastritis Negative Positive 
47. 1828/10 50/Male 
Patchy erthematous 
Changes of gastric 
mucosa 
Normal Gastric mucosa Negative Negative 
48. 2086/10 35/Male Duodenitis Chronic active gastritis Positive  Positive 
49. 1957/10 18/Male Duodenitis Chronic active gastritis Positive Positive 
50. 3646/10 32/Male Gastric ulcer 
Chronic  gastritis with 
intestinal metaplasia 
Negative Negative 
 
